Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells

Detalles Bibliográficos
Autores principales: Norris, E J, DeStephanis, D, Tunquist, B, Usmani, S, Ganapathi, R, Ganapathi, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098264/
https://www.ncbi.nlm.nih.gov/pubmed/27716742
http://dx.doi.org/10.1038/bcj.2016.92
_version_ 1782465752643665920
author Norris, E J
DeStephanis, D
Tunquist, B
Usmani, S
Ganapathi, R
Ganapathi, M
author_facet Norris, E J
DeStephanis, D
Tunquist, B
Usmani, S
Ganapathi, R
Ganapathi, M
author_sort Norris, E J
collection PubMed
description
format Online
Article
Text
id pubmed-5098264
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50982642016-11-18 Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells Norris, E J DeStephanis, D Tunquist, B Usmani, S Ganapathi, R Ganapathi, M Blood Cancer J Letter to the Editor Nature Publishing Group 2016-10 2016-10-07 /pmc/articles/PMC5098264/ /pubmed/27716742 http://dx.doi.org/10.1038/bcj.2016.92 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Norris, E J
DeStephanis, D
Tunquist, B
Usmani, S
Ganapathi, R
Ganapathi, M
Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells
title Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells
title_full Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells
title_fullStr Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells
title_full_unstemmed Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells
title_short Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells
title_sort cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098264/
https://www.ncbi.nlm.nih.gov/pubmed/27716742
http://dx.doi.org/10.1038/bcj.2016.92
work_keys_str_mv AT norrisej cytotoxicefficacyoffilanesibandmelphalancombinationisgovernedbysequenceoftreatmentinhumanmyelomacells
AT destephanisd cytotoxicefficacyoffilanesibandmelphalancombinationisgovernedbysequenceoftreatmentinhumanmyelomacells
AT tunquistb cytotoxicefficacyoffilanesibandmelphalancombinationisgovernedbysequenceoftreatmentinhumanmyelomacells
AT usmanis cytotoxicefficacyoffilanesibandmelphalancombinationisgovernedbysequenceoftreatmentinhumanmyelomacells
AT ganapathir cytotoxicefficacyoffilanesibandmelphalancombinationisgovernedbysequenceoftreatmentinhumanmyelomacells
AT ganapathim cytotoxicefficacyoffilanesibandmelphalancombinationisgovernedbysequenceoftreatmentinhumanmyelomacells

Ejemplares similares